Refine
Has Fulltext
- yes (40)
Is part of the Bibliography
- yes (40)
Year of publication
Document Type
Keywords
- Toxikologie (17)
- DNA damage (9)
- micronuclei (4)
- Micronuclei (3)
- oxidative stress (3)
- 5-Azacytidine (2)
- DNA repair (2)
- Diethylstilbestrol (2)
- Electropermeabilization (2)
- Elektrofusion (2)
- Elektroporation (2)
- Zelle (2)
- actinomycetes (2)
- apoptosis (2)
- cancer risk (2)
- comet assay (2)
- cytokinins (2)
- insulin (2)
- lymphocytes (2)
- (Mouse L-cell) (1)
- 1 (1)
- 2-Dioxetane (1)
- 6-benzylaminopurine (1)
- Alzheimers disease (1)
- Benzefuran dioxetane (1)
- Benzefuran epoxide (1)
- Berenil (1)
- Bromodeoxyuridine labeling (1)
- Calcium (1)
- Cell death and comet assay (1)
- Cell transformation (1)
- Chromosome distribution (1)
- DES (1)
- DNA adduct . Repair endonuclease (1)
- DNA damage response (1)
- DNA transfection (1)
- DNS-Schädigung (1)
- Drug resistance (1)
- Electric Field (1)
- Electrical breakdown (1)
- Ethionine (1)
- Eukaryotic cell (1)
- FPG protein (1)
- Flow cytometry (1)
- Gene Transfer (1)
- Gene transfer (1)
- Hoechst 33258 dye (1)
- Hybridoma (1)
- Kinetochore (1)
- Kinetochores (1)
- L5178Y cells (1)
- Medizin (1)
- Micronucleus formation (1)
- Mitosis (1)
- Mutagenicity (1)
- Neomycin Resistance (1)
- Salmonella/microsome assay (1)
- Stable Transformation (1)
- Streptomyces (1)
- TK6 cells (1)
- Toxin (1)
- Transfection (1)
- Unscheduled DNA synthesis (1)
- Volume distribution (1)
- Wachstumskonus (1)
- Zellskelett (1)
- ageing (1)
- antibacterial/antiviral drug (1)
- antioxidants (1)
- assay (1)
- association (1)
- bariatric surgery (1)
- base excision repair (incision activity) (1)
- biofilms (1)
- biology (1)
- biomarkers (1)
- blood samples (1)
- calcium (1)
- cell fate (1)
- cell staining (1)
- chronic kidney disease (1)
- co-culture (1)
- cognitive impairment (1)
- contact lens (1)
- continuous (1)
- cyclic dipeptide (1)
- cytochrome P450s (1)
- cytome biomarkers (1)
- cytoskeleton (1)
- cytotoxic (1)
- diabetes (1)
- diagnosis (1)
- dialysis (1)
- etoposide (1)
- fatty liver (1)
- fluorescence recovery after photobleaching (1)
- genomic damage (1)
- genotoxicity (1)
- growth cone (1)
- haematopoietic stem cells (1)
- human biomonitoring (1)
- insulin signaling (1)
- life (1)
- live imaging (1)
- liver (1)
- lovastatin (1)
- mTOR-inhibitor RAD-001 (1)
- maintenance of genomic integrity (1)
- mammalian genomics (1)
- marine sponges (1)
- medicine (1)
- membrane transporters (1)
- micronucleus test (1)
- mitotic disturbance (1)
- mouse lymphoma L5178Y (1)
- mouse models DNA damage (1)
- mutagenicity (1)
- obesity (1)
- peripheral-blood lymphocytes (1)
- poly(ADP-ribosyl)ation (1)
- pyrrolizidine alkaloids (1)
- rat pheochromocytoma cells (1)
- resveratrol (1)
- sex (1)
- sponges (1)
- staphilococci (1)
- streptomyces (1)
- thyroid hormone (1)
- uremic toxins (1)
Institute
- Institut für Pharmakologie und Toxikologie (40) (remove)
EU-Project number / Contract (GA) number
- 311932 (2)
Pyrrolizidine alkaloids (PAs) are secondary plant metabolites, which can be found as contaminant in various foods and herbal products. Several PAs can cause hepatotoxicity and liver cancer via damaging hepatic sinusoidal endothelial cells (HSECs) after hepatic metabolization. HSECs themselves do not express the required metabolic enzymes for activation of PAs. Here we applied a co-culture model to mimic the in vivo hepatic environment and to study PA-induced effects on not metabolically active neighbour cells. In this co-culture model, bioactivation of PA was enabled by metabolically capable human hepatoma cells HepG2, which excrete the toxic and mutagenic pyrrole metabolites. The human cervical epithelial HeLa cells tagged with H2B-GFP were utilized as non-metabolically active neighbours because they can be identified easily based on their green fluorescence in the co-culture. The PAs europine, riddelliine and lasiocarpine induced micronuclei in HepG2 cells, and in HeLa H2B-GFP cells co-cultured with HepG2 cells, but not in HeLa H2B-GFP cells cultured alone. Metabolic inhibition of cytochrome P450 enzymes with ketoconazole abrogated micronucleus formation. The efflux transporter inhibitors verapamil and benzbromarone reduced micronucleus formation in the co-culture model. Furthermore, mitotic disturbances as an additional genotoxic mechanism of action were observed in HepG2 cells and in HeLa H2B-GFP cells co-cultured with HepG2 cells, but not in HeLa H2B-GFP cells cultured alone. Overall, we were able to show that PAs were activated by HepG2 cells and the metabolites induced genomic damage in co-cultured HeLa cells.